Joe Larsen
About Joe Larsen
Title: Vice President of Clinical Development
Joe Larsen currently holds the position of Vice President of Clinical Development. In this role, he is responsible for overseeing the clinical development of pharmaceuticals and medical countermeasures. His work involves managing the development process from early-stage research to late-stage clinical trials, ensuring that projects meet regulatory requirements and clinical objectives.
Past Role: Vice President, Strategic Portfolio Development at Venatorx Pharmaceuticals
Prior to his current position, Joe Larsen served as Vice President of Strategic Portfolio Development at Venatorx Pharmaceuticals. In this capacity, he was responsible for guiding the strategic direction of the company's portfolio. His duties included identifying opportunities for new products, managing the development pipeline, and aligning projects with the company's long-term goals.
Government Experience: Deputy Director at BARDA
Joe Larsen spent ten years in the federal government, where he held significant roles, including as Deputy Director of Chemical, Biological, Radiological, and Nuclear (CBRN) medical countermeasures at the Biomedical Advanced Research and Development Authority (BARDA). In this role, Larsen oversaw the development and procurement of critical medical countermeasures, managing the $2.8 billion Project Bioshield fund to ensure preparedness against CBRN threats.
Education: Ph.D. in Microbiology and Immunology
Joe Larsen earned his Ph.D. in microbiology and immunology from the Uniformed Services University of the Health Sciences. This advanced degree provided him with a deep understanding of pathogens and the immune system, equipping him with the expertise required for his roles in clinical and strategic development in pharmaceuticals and government.
Educational Background: B.A. in Microbiology
Joe Larsen holds a Bachelor of Arts degree in microbiology from the University of Kansas. This foundational education in microbiology established the groundwork for his subsequent advanced studies and his career in the development of medical countermeasures and pharmaceuticals.